Form 4 holding
Director
Kyverna Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 4,523,924
- Estimated value
- $39,041,464
- Report date
- 27 May 2026
- Price
- $8.63
- Ownership
- Indirect
Fred E. Cohen - Director at Kyverna Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- KYTX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Fred E. Cohen since 12 Aug 2025
Reported holdings for Fred E. Cohen in Kyverna Therapeutics, Inc.
Form 4 holding
Director
Kyverna Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 21,727
- Estimated value
- $187,504
- Report date
- 27 May 2026
- Price
- $8.63
- Ownership
- Direct
Form 4 holding
Director
Kyverna Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 20,582
- Estimated value
- Report date
- 27 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Fred E. Cohen in Kyverna Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.